Overview A Trial of LY3056480 in Patients With SNLH Status: Not yet recruiting Trial end date: 2025-03-01 Target enrollment: Participant gender: Summary A phase 2 trial with LY3056480 in patients with stable SNHL Phase: Phase 2 Details Lead Sponsor: Audion Therapeutics BV